Pharmaceuticals & Healthcare
With over a decade of experience advising the largest companies in the sector, Sayenko Kharenko has a strong competitive edge. This includes an unmatched understanding of the industry and the dynamics that drive it, together with a network of business contacts within the industry and strong working relations with Ukrainian regulators.
Sayenko Kharenko’s multidisciplinary group advises clients across the full breadth of issues related to developing, importing, manufacturing and marketing pharmaceuticals and medical products in Ukraine.
We customarily assist both national and international clients on the most challenging sector-specific issues:
- regulatory issues applicable to the pharmaceutical sector in Ukraine
- anti-corruption and compliance
- customs related issues
- public procurement proceedings
- antitrust and competition
- IP matters (contentious and non-contentious)
- commercial agreements including licensing, research and development
- corporate and transactional needs (financings, M&A transactions, etc.)
- dispute resolution
- advertising and promotion of pharmaceuticals and medical products
- personal data protection
We have worked on deals involving some of the largest Ukrainian and international companies, including: Abbott, AbbVie, Actavis, Bausch & Lomb, Bayer, Boehringer Ingelheim, Borshchagivskiy chemical-pharmaceutical plant, Dentsply Sirona, Eli Lilly, Ferrosan, Gerot Pharmazeutika, GlaxoSmithKline, Merck, Novartis, Nycomed, Obagi Medical Products, Ostrov Juice, Pfizer, Perrigo, Reckitt Benckiser Household & Healthcare, Sanofi, Sigma-Aldrich, Solvay, Ukrmedpack, Unique Pharma, Valeant Pharmaceuticals, Watson Pharmaceuticals, Zentiva and others.
The Pharma Legal Handbook Ukraine
Neither new AMCU approaches, nor high standards of doing business are “magic bullets” for investigations (in Ukrainian)
Anti-dumping investigation into the import of syringes originating in China, Turkey and India (in Ukrainian)
Anti-dumping investigation into the import of syringes originating in China, Turkey and India (in Russian)
Overview on the Ukrainian pharmaceutical industry in 2017
Ukraine accepts protocol amending the TRIPS Agreement: terra incognita (in Russian)
